Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05180383 · ClinicalTrials.gov registry record · NA
Examining Feasibility, Acceptability, and Sustainability of a Novel Personalized Smartphone Intervention for Suicide - Open Trial
A NA study, sponsored by Butler Hospital.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT05180383 is a NA study that has completed, run by Butler Hospital. The registered enrollment target is 10 participants.
The verdict
NCT05180383, a NA study, has completed, sponsored by Butler Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The primary aim of the present study is leverage existing infrastructure to develop novel technological features for a novel personalized smartphone intervention system, called the Mobile Application to Prevent Suicide (MAPS), and to establish feasibility, acceptability, safety, and estimate key parameters for secondary outcomes (i.e., suicidal ideation and behavior; re-hospitalization).
Interventions
- BEHAVIORAL Mobile Application to Prevent Suicide (MAPS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2023-12-05 |
| Est. Completion | 2025-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05180383
The ClinicalTrials.gov registry entry for NCT05180383 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Butler Hospital, which has 103 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mobile Application to Prevent Suicide (MAPS) is the first listed.
NCT05180383 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05180383 about?
NCT05180383 is a clinical study titled "Examining Feasibility, Acceptability, and Sustainability of a Novel Personalized Smartphone Intervention for Suicide - Open Trial". The primary aim of the present study is leverage existing infrastructure to develop novel technological features for a novel personalized smartphone intervention system, called the Mobile Application to Prevent Suicide (MAPS), and to establish feasibility, acceptability, safety, and estimate key par...
What is the current status of trial NCT05180383?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2023-12-05. Estimated completion is 2025-04-30.
What interventions are being tested in trial NCT05180383?
The interventions under investigation include: Mobile Application to Prevent Suicide (MAPS) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05180383?
This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.